Longboard Pharmaceuticals Inc (NASDAQ: LBPH) is 879.77% higher on its value in year-to-date trading and has touched a low of $3.60 and a high of $59.12 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LBPH stock was last observed hovering at around $58.99 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $59.08, the stock is 62.44% and 67.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.51 million and changing 0.15% at the moment leaves the stock 126.37% off its SMA200. LBPH registered 1074.55% gain for a year compared to 6-month gain of 223.73%. The firm has a 50-day simple moving average (SMA 50) of $35.3542 and a 200-day simple moving average (SMA200) of $26.098625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 92.19% loss in the last 1 month and extending the period to 3 months gives it a 63.11%, and is 75.68% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.71% over the week and 9.20% over the month.
Longboard Pharmaceuticals Inc (LBPH) has around 50 employees, a market worth around $2.30B and $0.00M in sales. Distance from 52-week low is 1541.11% and -0.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.71%).
The EPS is expected to grow by 7.95% this year.
Longboard Pharmaceuticals Inc (LBPH) Top Institutional Holders
167.0 institutions hold shares in Longboard Pharmaceuticals Inc (LBPH), with institutional investors hold 120.95% of the company’s shares. The shares outstanding are 38.90M, and float is at 33.57M with Short Float at 16.01%. Institutions hold 119.36% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.42 million shares valued at $119.34 million. The investor’s holdings represent 11.3559% of the LBPH Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 3.29 million shares valued at $88.9 million to account for 8.4596 of the shares outstanding. The other top investors are FARALLON CAPITAL MANAGEMENT LLC which holds 2.94 million shares representing 7.5629% and valued at over $79.48 million, while CORMORANT ASSET MANAGEMENT, LP holds 7.1771 of the shares totaling 2.79 million with a market value of $75.43 million.
Longboard Pharmaceuticals Inc (LBPH) Insider Activity
The most recent transaction is an insider sale by Kaye Randall, the company’s CMO. SEC filings show that Kaye Randall sold 16,666 shares of the company’s common stock on Sep 16 ’24 at a price of $31.64 per share for a total of $0.53 million. Following the sale, the insider now owns 17920.0 shares.
Still, SEC filings show that on Jan 23 ’24, Kaye Randall (CMO) acquired 100 shares at an average price of $24.82 for $2482.0. The insider now directly holds 100 shares of Longboard Pharmaceuticals Inc (LBPH).
